A phase 2a, double-blind, randomised, placebo-controlled trial of the myeloperoxidase inhibitor, ...
August 7, 2026
Share
A phase 2a, double-blind, randomised, placebo-controlled trial of the myeloperoxidase inhibitor, mitiperstat, in participants with chronic obstructive pulmonary disease
